Oxalic Acid

Oxalic Acid

SCHEMBL4158692

O=C(O)C(=O)O.O=C(O)N[C@H]1CC[C@@H](N2CCCC2)CC1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.49
POLB P06746 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CHRM5 P08912 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM3 P20309 1/20 0.41
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
L3MBTL3 Q96JM7 3/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15190856 0.96 SIGMAR1 (0.51) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL3272638 0.96 SIGMAR1 (0.51) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL3272642 0.96 SIGMAR1 (0.51) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL4777482 0.94 SIGMAR1 (0.54) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL4777474 0.94 SIGMAR1 (0.54) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL22191535 0.92 SIGMAR1 (0.48) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL22208127 0.84 POLB (0.46) SIGMAR1POLBHSD17B10MEN1KMT2A
SCHEMBL26093476 0.81 CHRM1 (0.46) SIGMAR1POLBHSD17B10CHRM5CHRM1
SCHEMBL26093471 0.81 CHRM1 (0.46) SIGMAR1POLBHSD17B10CHRM5CHRM1
SCHEMBL23573288 0.81 POLB (0.56) SIGMAR1POLBHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090093474-A1 THIAZOLYL-DIHYDRO-INDAZOLE GRAUERT MATTHIAS 2009-04-09 US disclosed
US-20070238718-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093474-A1 THIAZOLYL-DIHYDRO-INDAZOLE CYP3A43, CYP3A5, UGT1A3 SIGMAR1 1315/4885POLB 4373/4885HSD17B10 564/4885
US-20070238718-A1 THIAZOLYL-DIHYDRO-INDAZOLE CYP3A43, CYP3A5, UGT1A3 SIGMAR1 1315/4885POLB 4373/4885HSD17B10 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.